Showing results (81-90 of 491) with videos related to
Sort By:
Pageof 50
Prostaglandins and Medicine|December 1, 1980
The effect of hypercholesterolaemia on the lipid composition and ability of human platelets to accumulate cyclic AMPJ A Jakubowski, N G Ardlie, P J NestelJournal of Mass Spectrometry : JMS|June 4, 2005
Online microdialysis-dynamic nanoelectrospray ionization-mass spectrometry for monitoring neuropeptide secretionJennifer A Jakubowski, Nathan G Hatcher, Jonathan V SweedlerJournal of Immunology (Baltimore, Md. : 1950)|June 15, 1987
Humoral response in Treponema pallidum-infected guinea pigs. II. Circulating immune complexes and autoimmune responsesR E Baughn, V Wicher, A Jakubowski, et al.Leukemia|May 1, 1989
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195M Tanimoto, D A Scheinberg, C Cordon-Cardo, et al.Blood|May 1, 1996
Specific human cellular immunity to bcr-abl oncogene-derived peptidesM Bocchia, T Korontsvit, Q Xu, et al.The Journal of Experimental Medicine|October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodiesP C Caron, W Laird, M S Co, et al.Blood|May 15, 1995
Specific binding of leukemia oncogene fusion protein peptides to HLA class I moleculesM Bocchia, P A Wentworth, S Southwood, et al.The Journal of Biological Chemistry|June 25, 1982
Effect of membrane cholesterol on phospholipid metabolism in thrombin-stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acidR M Kramer, J A Jakubowski, R Vaillancourt, et al.Cardiovascular Drug Reviews|December 15, 2007
Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profileJoseph A Jakubowski, Kenneth J Winters, Hideo Naganuma, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|April 8, 2006
Inhibition of NOS-2 induction in LPS-stimulated J774.2 cells by 1, 5-isoquinolinediol, an inhibitor of PARPR Olszanecki, A Gebska, J Jawień, et al.Pageof 50